D57.432
Sickle-cell thalassemia beta zero with splenic sequestration
Clinical Classification Guidelines
Inclusion Terms
- HbS-beta zero with splenic sequestration
- Sickle-cell beta zero with splenic sequestration
Medical Intelligence & Overview
Sickle-cell thalassemia beta zero with splenic sequestration is a complex blood disorder that combines features of sickle cell disease and thalassemia, leading to significant health issues. This condition is characterized by abnormal hemoglobin production and episodes where blood cells become misshapen and get trapped in the spleen, causing a sudden drop in blood volume. Recognizing and managing this condition is crucial for preventing serious complications and maintaining quality of life.
Causes & Symptoms
Clinical Causes: T h e c o n d i t i o n a r i s e s d u e t o g e n e t i c m u t a t i o n s a f f e c t i n g h e m o g l o b i n p r o d u c t i o n , i n h e r i t e d f r o m p a r e n t s . S p e c i f i c a l l y , i t i n v o l v e s t h e i n h e r i t a n c e o f b o t h s i c k l e c e l l a n d b e t a - z e r o t h a l a s s e m i a g e n e s , l e a d i n g t o d e f e c t i v e h e m o g l o b i n ( H b S ) a n d r e d u c e d o r a b s e n t b e t a - g l o b i n c h a i n s . T h i s g e n e t i c c o m b i n a t i o n r e s u l t s i n a b n o r m a l r e d b l o o d c e l l f o r m a t i o n a n d f u n c t i o n , w h i c h c a n i n c l u d e e p i s o d e s o f s p l e n i c s e q u e s t r a t i o n .
Key Symptoms: Sudden weakness or fatigue due to anemia Paleness of skin and mucous membranes Enlarged spleen causing abdominal pain or discomfort Rapid heartbeat Fever or signs of infection Jaundice (yellowing of the skin and eyes) Symptoms of hypovolemia, such as dizziness or lightheadedness during splenic sequestration episodes
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of blood tests and genetic analysis. Key methods include: - Complete blood count (CBC) showing anemia with abnormal red blood cell shape - Hemoglobin electrophoresis to identify abnormal hemoglobin variants - Genetic testing to confirm mutations associated with sickle cell and beta-zero thalassemia - Imaging studies such as ultrasound to assess spleen size and detect sequestration episodes These diagnostic tools help to distinguish this particular form of sickle-cell thalassemia and guide appropriate management strategies.
Treatment Protocols: Management of sickle-cell thalassemia beta zero with splenic sequestration focuses on preventing episodes, treating symptoms, and avoiding complications. Treatment options include: - Regular blood transfusions to reduce sickled cells and anemia - Iron chelation therapy to prevent iron overload from transfusions - Pain management during sickle cell crises - Splenectomy (surgical removal of the spleen) in severe or recurrent sequestration episodes - Antibiotic prophylaxis to prevent infections - Hydroxyurea therapy, which can reduce the frequency of sickling episodes - Patient education on recognizing early signs of splenic sequestration and when to seek emergency care Close medical follow-up and comprehensive care are essential to improve outcomes and quality of life for individuals affected by this condition.
Clinical Advice & FAQs
Billing Guidance
Is D57.432 a billable ICD-10 code?
Yes, D57.432 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D57.432?
Clinical documentation must specify the nature of Sickle-cell thalassemia beta zero with splenic sequestration and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
